Rice's Drezek wins $3M grant for breast cancer research

January 08, 2007

HOUSTON, Jan. 8, 2007 - The Department of Defense (DOD) has named Rice University the recipient of a $3 million award for a five-year program to develop miniaturized molecular imaging technologies for screening, diagnosis, and monitoring of breast cancer. The program, which will be conducted in collaboration with The University of Texas M. D. Anderson Cancer Center, calls for the development of microendoscope and needle-compatible fiber optic systems that doctors can use for a variety of diagnostic and therapeutic breast cancer imaging needs, ranging from early detection to guiding surgery to monitoring the efficacy of radiation therapy and targeted drug treatments.

The program's principal investigator, Rice bioengineer Rebekah Drezek, is one of three U.S. scientists chosen by the DOD for this year's Era of Hope Scholar Award, which is given annually by the DOD's Congressionally Directed Breast Cancer Research Program (BCRP).

The award recognizes "exceptionally talented, early-career scientists who have demonstrated through their extraordinary creativity, vision and productivity that they are the best and brightest in their fields."

Drezek, associate professor in both bioengineering and in electrical and computer engineering, was selected for her translational research developing miniaturized photonics-based molecular imaging technologies for screening, diagnosis, and monitoring of breast cancer. She is the first Rice faculty member to receive the Era of Hope Scholar Award and is the only principal investigator chosen this year that is not at a medical institution.

"Medical imaging plays a critical role in all aspects of breast cancer care," Drezek said. "From initial screening and diagnosis to guiding and monitoring therapeutic interventions, doctors use a variety of imaging technologies like x-rays, ultrasound and magnetic resonance imaging, or MRI. But all of these technologies provide low-resolution, non-specific anatomic images of tissue."

Research in Drezek's lab takes a different approach to clinical breast cancer imaging, focusing on the development of inexpensive, portable photonic-based imaging tools that provide high-resolution in situ imaging of the molecular hallmarks of breast cancer.

"In current practice, doctors need to biopsy a tumor in order to conduct the chemical tests that find the molecular signatures of different types of cancer," Drezek said. "There is a tremendous need for novel technologies that can detect biomarkers without tissue removal."

Drezek said most optical imaging research to date has focused on screening, but the dramatic expansion of new, targeted cancer therapies has created a substantial need for imaging tools that can monitor the efficacy of molecular-targeted therapeutics. Drezek's research group uses an interdisciplinary bench-to-bedside approach to develop imaging tools that ultimately can be used to monitor therapies including chemotherapy, radiation therapy, and surgery. Kuan Yu, assistant professor of radiation oncology, will lead the portion of the research conducted at M. D. Anderson.

"By combining our lab's expertise with that of our clinical partners at M. D. Anderson, we hope to take advantage of parallel advances in micro-optics, nanoscale imaging agents, and breast cancer biomarker identification to enable a completely different approach to molecular imaging of breast cancer than was possible just a few years ago," Drezek said. "More importantly, we want to have the clinical partners in place to help us continually adjust our path forward so that we are always directing our efforts towards those areas of medical need where we will be able to make most direct and significant impact on patient care."
-end-
Other significant honors Drezek has received include the Massachusetts Institute of Technology's TR100 World's 100 Top Young Innovator Award (2004), the Beckman Young Investigator Award (2005), and the American Association for Medical Instrumentation Becton Dickinson Career Achievement Award (2005). Last year, Drezek was an invited speaker at the National Academy of Engineering's Frontiers in Engineering (2006).

Congress established the Department of Defense Congressionally Directed Breast Cancer Research Program (BCRP) in 1992 in response to lobbying efforts by advocacy organizations that sought research specifically designed to address breast cancer. The DOD was chosen because of its long history in medical research and responsiveness to unmet medical need. BCRP is second only to the National Cancer Institute as a U.S. funding source for breast cancer research.

Rice University

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.